• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

复发对早期癌症患者及其照料者的就业、财务状况和生产力的影响：美国的调查。

Impact of recurrence on employment, finances, and productivity for early-stage cancer patients and caregivers: US survey.

作者信息

Aguiar-Ibáñez Raquel, McQuarrie Kelly, Jayade Sayeli, Penton Hannah, DiGiovanni Laura, Raina Rutika, Heisen Marieke, Martinez Ana

机构信息

Merck Canada Inc., Kirkland, QC, Canada.

Merck & Co., Inc., Rahway, NJ, USA.

出版信息

Future Oncol. 2025 Feb;21(3):349-365. doi: 10.1080/14796694.2024.2436342. Epub 2024 Dec 16.

DOI:10.1080/14796694.2024.2436342
PMID:39676564
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11792841/
Abstract

BACKGROUND

Following an early-stage cancer diagnosis, recurrences can occur. To quantify financial impacts of a first recurrence, we surveyed patients and caregivers.

METHODS

The survey was self-administered online to patients ( = 202) with early-stage bladder, gastric, head and neck, melanoma, non-small cell lung, renal cell, and triple-negative breast cancers that recurred and caregivers ( = 100) of such patients. Work productivity and financial impacts were explored.

RESULTS

Negative impacts on work productivity, employment, finances, and healthcare resource use were identified, with significant differences seen across cancer types, between locoregional and distant/metastatic recurrences, and from pre-recurrence to post-recurrence.

CONCLUSIONS

The financial burden to patients, caregivers, healthcare systems, and society following early-stage cancer recurrence is substantial. Treatments that decrease recurrences can reduce this burden.

摘要

背景

早期癌症诊断后可能会出现复发情况。为了量化首次复发的经济影响，我们对患者及其护理人员进行了调查。

方法

通过在线方式对患有早期膀胱癌、胃癌、头颈癌、黑色素瘤、非小细胞肺癌、肾细胞癌和三阴性乳腺癌且出现复发的患者（n = 202）及其护理人员（n = 100）进行了自行填写式调查。探讨了工作效率和经济影响。

结果

确定了对工作效率、就业、财务和医疗资源使用的负面影响，不同癌症类型之间、局部复发与远处/转移性复发之间以及复发前至复发后均存在显著差异。

结论

早期癌症复发给患者、护理人员、医疗系统和社会带来的经济负担巨大。减少复发的治疗方法可以减轻这一负担。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6fd/11792841/eb4ce54b5fe8/IFON_A_2436342_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6fd/11792841/ad908150c3bb/IFON_A_2436342_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6fd/11792841/0284eff76052/IFON_A_2436342_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6fd/11792841/ba6d076200b0/IFON_A_2436342_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6fd/11792841/3c38c981efe8/IFON_A_2436342_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6fd/11792841/eb4ce54b5fe8/IFON_A_2436342_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6fd/11792841/ad908150c3bb/IFON_A_2436342_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6fd/11792841/0284eff76052/IFON_A_2436342_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6fd/11792841/ba6d076200b0/IFON_A_2436342_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6fd/11792841/3c38c981efe8/IFON_A_2436342_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6fd/11792841/eb4ce54b5fe8/IFON_A_2436342_F0005_OC.jpg

相似文献

1
Impact of recurrence on employment, finances, and productivity for early-stage cancer patients and caregivers: US survey.复发对早期癌症患者及其照料者的就业、财务状况和生产力的影响：美国的调查。
Future Oncol. 2025 Feb;21(3):349-365. doi: 10.1080/14796694.2024.2436342. Epub 2024 Dec 16.
2
A US Survey Across Seven Early-Stage Cancers Assessing the Humanistic Burden of Recurrence on Patients and Caregivers.一项针对七种早期癌症的美国调查，评估复发对患者和照顾者的人文负担。
Oncol Ther. 2025 Jun;13(2):339-361. doi: 10.1007/s40487-025-00328-4. Epub 2025 Mar 25.
3
The burden of metastatic breast cancer on caregiver productivity and quality of life: A survey study in the United States, United Kingdom, and Germany.转移性乳腺癌对护理人员工作效率和生活质量的影响：一项在美国、英国和德国开展的调查研究。
J Cancer Policy. 2025 Mar;43:100526. doi: 10.1016/j.jcpo.2024.100526. Epub 2024 Dec 2.
4
United States Patients' Perspective of Living With Migraine: Country-Specific Results From the Global "My Migraine Voice" Survey.美国偏头痛患者生活状况的调查结果：来自全球“我的偏头痛声音”调查的国家特异性结果。
Headache. 2020 Jul;60(7):1351-1364. doi: 10.1111/head.13829. Epub 2020 May 5.
5
The economic impact of caregiving for individuals with Angelman syndrome in the United States: results from a caregiver survey.美国照顾患有天使综合征个体的经济影响：一项照顾者调查结果
Orphanet J Rare Dis. 2025 Feb 21;20(1):82. doi: 10.1186/s13023-025-03551-4.
6
Economic burden and quality of life of caregivers of patients with sickle cell disease in the United Kingdom and France: a cross-sectional study.英国和法国镰状细胞病患者照顾者的经济负担和生活质量：一项横断面研究。
J Patient Rep Outcomes. 2024 Sep 26;8(1):110. doi: 10.1186/s41687-024-00784-y.
7
The Economic Burden of Recurrence in Triple-Negative Breast Cancer Among Working Age Patients in the United States.美国工作年龄患者三阴性乳腺癌复发的经济负担。
Adv Ther. 2022 Feb;39(2):943-958. doi: 10.1007/s12325-021-01913-5. Epub 2021 Dec 17.
8
Cost burden associated with advanced non-small cell lung cancer in Europe and influence of disease stage.欧洲晚期非小细胞肺癌的费用负担及其与疾病分期的关系。
BMC Cancer. 2019 Mar 8;19(1):214. doi: 10.1186/s12885-019-5428-4.
9
Caregiver burden, productivity loss, and indirect costs associated with caring for patients with poststroke spasticity.照顾中风后痉挛患者的照护者负担、生产力损失及间接成本。
Clin Interv Aging. 2015 Nov 6;10:1793-802. doi: 10.2147/CIA.S91123. eCollection 2015.
10
Real-world study of the impact of recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) on quality of life and productivity in Europe.在欧洲，复发性/转移性头颈部鳞状细胞癌（R/M SCCHN）对生活质量和生产力的真实世界研究。
BMC Cancer. 2021 Jul 24;21(1):854. doi: 10.1186/s12885-021-08557-2.

引用本文的文献

1
The Health Impact of Using Anti-PD-1 Agents to Treat Early-Stage Cancer in Belgium.在比利时使用抗程序性死亡蛋白1（Anti-PD-1）药物治疗早期癌症对健康的影响。
Oncol Ther. 2025 Jul 24. doi: 10.1007/s40487-025-00357-z.
2
Clinical, humanistic and economic burden associated with recurrence among patients with early-stage cancers: a systematic literature review.早期癌症患者复发相关的临床、人文和经济负担：一项系统文献综述
Front Oncol. 2025 May 26;15:1575813. doi: 10.3389/fonc.2025.1575813. eCollection 2025.
3
A US Survey Across Seven Early-Stage Cancers Assessing the Humanistic Burden of Recurrence on Patients and Caregivers.

本文引用的文献

1
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma.帕博利珠单抗辅助治疗用于肾细胞癌的总生存期。
N Engl J Med. 2024 Apr 18;390(15):1359-1371. doi: 10.1056/NEJMoa2312695.
2
Cancer statistics, 2024.2024年癌症统计数据。
CA Cancer J Clin. 2024 Jan-Feb;74(1):12-49. doi: 10.3322/caac.21820. Epub 2024 Jan 17.
3
Event-free survival as a predictor of overall survival and recurrence burden of patients with non-small cell lung cancer receiving neoadjuvant therapy.接受新辅助治疗的非小细胞肺癌患者的无事件生存预测总生存和复发负担。
一项针对七种早期癌症的美国调查，评估复发对患者和照顾者的人文负担。
Oncol Ther. 2025 Jun;13(2):339-361. doi: 10.1007/s40487-025-00328-4. Epub 2025 Mar 25.
J Thorac Cardiovasc Surg. 2024 Oct;168(4):1261-1269.e1. doi: 10.1016/j.jtcvs.2023.12.006. Epub 2023 Dec 12.
4
Evaluation of disease-free survival as a predictor of overall survival and assessment of real-world burden of disease recurrence in resected early-stage non-small cell lung cancer.评估无病生存期作为总生存期的预测指标，并评估早期非小细胞肺癌切除术后疾病复发的真实世界负担。
J Manag Care Spec Pharm. 2023 Jul;29(7):749-757. doi: 10.18553/jmcp.2023.29.7.749.
5
Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer.帕博利珠单抗用于早期非小细胞肺癌的围手术期治疗。
N Engl J Med. 2023 Aug 10;389(6):491-503. doi: 10.1056/NEJMoa2302983. Epub 2023 Jun 3.
6
Clinical and economic impact of recurrence in early-stage non-small-cell lung cancer following complete resection.早期非小细胞肺癌完全切除术后复发的临床和经济影响。
Future Oncol. 2023 Jun;19(20):1415-1427. doi: 10.2217/fon-2023-0024. Epub 2023 May 23.
7
Economic Burden of Recurrence Among Resected Medicare Patients With Early Stage NSCLC.早期非小细胞肺癌切除术后医疗保险患者复发的经济负担
JTO Clin Res Rep. 2023 Feb 25;4(4):100487. doi: 10.1016/j.jtocrr.2023.100487. eCollection 2023 Apr.
8
Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.帕博利珠单抗对比安慰剂用于肾透明细胞癌肾切除术患者的辅助治疗（KEYNOTE-564）：一项多中心、随机、双盲、安慰剂对照、III 期临床试验的 30 个月随访分析。
Lancet Oncol. 2022 Sep;23(9):1133-1144. doi: 10.1016/S1470-2045(22)00487-9.
9
Clinical and economic burdens of recurrence following nephrectomy for intermediate high- or high-risk renal cell carcinoma: A retrospective analysis of Surveillance, Epidemiology, and End Results-Medicare data.肾细胞癌肾切除术后复发的临床和经济负担：监测、流行病学和最终结果-医疗保险数据的回顾性分析。
J Manag Care Spec Pharm. 2022 Oct;28(10):1149-1160. doi: 10.18553/jmcp.2022.22133. Epub 2022 Sep 1.
10
Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial.帕博利珠单抗对比安慰剂作为完全切除的IIB期或IIC期黑色素瘤辅助治疗（KEYNOTE-716）：一项随机、双盲、3期试验
Lancet. 2022 Apr 30;399(10336):1718-1729. doi: 10.1016/S0140-6736(22)00562-1. Epub 2022 Apr 1.